SLP

Simulations Plus, Inc.

A maker of computer software that lets pharmaceutical companies test drugs "on screen" before they ever reach a lab or a patient. Its tools—like GastroPlus, ADMET Predictor, and DILIsym—predict how a compound moves through the body and whether it might harm the liver, and its services help with modeling and clinical trial training. Founder Walt Woltosz started the company in 1996 after bringing aerospace-style simulation ideas into drug development. Its name simply joins "simulations" with a "plus," a nod to the extra technology baked in.

Recent Activity

Show $

2026Q2

1 buy

First Eagle Investment ManagementADD

+328.5K shares(+44.3%)

First Eagle Investment ManagementADD

+328.5K shares(+44.3%)

2026Q1

1 buy

First Eagle Investment ManagementADD

+284.9K shares(+62.3%)

First Eagle Investment ManagementADD

+284.9K shares(+62.3%)

Loading more activity...